Author:
Esquenazi Alberto,Ayyoub Ziyad,Verduzco-Gutierrez Monica,Maisonobe Pascal,Otto James,Patel Atul T.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference28 articles.
1. Doan QV, Brashear A, Gillard PJ, Varon SF, Vandenburgh AM, Turkel CC, et al. Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity. PM&R. 2012;4(1):4–10.
2. Royal College of Physicians (UK). Spasticity in adults: management using botulinum toxin. National guidelines 2018. https://www.rcplondon.ac.uk/guidelines-policy/spasticity-adults-management-using-botulinum-toxin. Last accessed Jul 2021.
3. Simpson DM, Hallett M, Ashman EJ. Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Neurology. 2016;86:1–9.
4. Esquenazi A, Albanese A, Chancellor MB, Elovic E, Segal KR, Simpson DM, et al. Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome. Toxicon. 2013;67:115–28.
5. Bigalke H. Properties of pharmaceutical products of botulinum neurotoxins. In: Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallett M, Mayer NH, editors. Botulinum toxin: therapeutic clinical practice and science. Philadelphia: Saunders Elsevier; 2009. p. 389–97.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献